Hing Y. Leung
Impact in
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Kruppel-like factors research
Papers in
-
- Prostate Cancer Treatment and Research 80
- Prostate Cancer Diagnosis and Treatment 28
-
- Cancer, Lipids, and Metabolism 17
- Co-authors
- Craig RobsonDavid E. NealImran AhmadVincent J. GnanapragasamLuke GaughanSusan CookOwen J. SansomPrabhakar Rajan
- Journals
- British Journal of Cancer (20 papers)Oncogene (13 papers)British Journal of Urology (11 papers)The Journal of Pathology (8 papers)PLoS ONE (7 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Hing Y. Leung
201 papers receiving 7.7k citations
Peers
Comparison fields: 5 of 147
- Cancer Research 1.8k
- Molecular Biology 5.3k
- Pulmonary and Respiratory Medicine 2.1k
- Oncology 1.6k
- Cell Biology 637
Countries citing papers authored by Hing Y. Leung
This map shows the geographic impact of Hing Y. Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hing Y. Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hing Y. Leung more than expected).
Fields of papers citing papers by Hing Y. Leung
This network shows the impact of papers produced by Hing Y. Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hing Y. Leung. The network helps show where Hing Y. Leung may publish in the future.
Co-authors
The 25 scholars most cited alongside Hing Y. Leung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 31 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 10 | |
| 11 | 2017 | 15 | |
| 12 | 2015 | 8 | |
| 13 | 2013 | 5 | |
| 14 | 2012 | 158 | |
| 15 | 2011 | 20 | |
| 16 | 2009 | 74 | |
| 17 | 2008 | 32 | |
| 18 | 2006 | 131 | |
| 19 | Over-expression of fibroblast growth factor-8 in human prostate cancer. | 1996 | 57 |
| 20 | 1992 | 15 |
About Hing Y. Leung
Hing Y. Leung is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Urology, Molecular Biology and Oncology, having authored 204 papers that have together received 7.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (80 papers), Fibroblast Growth Factor Research (32 papers), Prostate Cancer Diagnosis and Treatment (28 papers), Cancer, Lipids, and Metabolism (17 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Wnt/β-catenin signaling in development and cancer (11 papers), Kruppel-like factors research (11 papers) and Bladder and Urothelial Cancer Treatments (11 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (5.3k citations), Pulmonary and Respiratory Medicine (2.1k citations), Oncology (1.6k citations) and Cell Biology (637 citations). Hing Y. Leung has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Craig Robson, David E. Neal, Imran Ahmad, Vincent J. Gnanapragasam, Luke Gaughan, Susan Cook, Owen J. Sansom, Prabhakar Rajan, Joanne Edwards and David J. Elliott. Their work appears in journals such as British Journal of Cancer, Oncogene, British Journal of Urology, The Journal of Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.